Delivery Order SPE2DB22D3501-SPE2DB26FTL17
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,185.65 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025. This firm fixed price delivery order, which represents a child contract under a larger vehicle, is set to reach completion by October 14, 2025. The award was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,762.72 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 14, 2025, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $7,940.72 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 120 capsules of the pharmaceutical TAFINLAR 75 MG. Performance will take place in Conshohocken, Pennsylvania under a start date of June 26, 2023 concluding on July 18, 2023. The contract calls for the delivery of 120 capsules of TAFINLAR 75 MG to support DLA's medical supply chain responsibilities....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,674.77 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of September 2, 2025, and represents a child contract under the company's broader relationship with the federal government. The award carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $75,646.20 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award demonstrating the vendor's capability to fulfill federal pharmaceutical procurement requirements. The delivery order is scheduled for ultimate completion on...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $23,237.52 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. This firm fixed-price delivery order, issued without set-aside designation, is a competitive award that leverages the vendor's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The order will be fulfilled at the company's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,235.60 by the Defense Logistics Agency's Medical Supply Chain on October 12, 2025. This firm fixed-price contract, which represents a child order under a larger vehicle, is scheduled for completion by October 14, 2025. The award was made through competitive procurement with no set-aside designation, reflecting the contractor's demonstrated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,315 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which concludes on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $440,428.52 by the Defense Logistics Agency's Medical Supply Chain on October 14, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of October 15, 2025, and was competitively awarded without set-aside designation. The order is to be performed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 2, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain for $1,859.79 under firm fixed price terms. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 3, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL17Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 7, 2025, by the Defense Logistics Agency (DLA) for TAFINLAR 75 mg capsules (120-count units) with a ceiling value of $17,730.91. The contract is structured as a firm fixed-price delivery order with a completion date of December 2, 2025. This award was not designated as a set-aside and was competitively awarded, consistent with AmerisourceBergen's track record of meeting federal procurement requirements through open competition. The place of performance is listed as the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The contract serves critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/7/25 |